U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H7O3.Na
Molecular Weight 174.1291
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Sodium 3-methylsalicylate

SMILES

[Na+].CC1=CC=CC(C([O-])=O)=C1O

InChI

InChIKey=ODAXNLPYGWAGTH-UHFFFAOYSA-M
InChI=1S/C8H8O3.Na/c1-5-3-2-4-6(7(5)9)8(10)11;/h2-4,9H,1H3,(H,10,11);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C8H7O3
Molecular Weight 151.1394
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Hydroxytoluic acid is a long-acting derivative of salicylate with antilipidemic properties. It shows fibrinolytic activity in human plasma by activating the fibrinolytic system and has been shown to lower plasma free fatty acid, cholesterol levels, and to raise metabolic oxygen consumption.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Mechanisms influencing the vasoactive effects of lidocaine in human skin.
2007 Feb
Photophysical properties of lanthanide hybrids covalently bonded to functionalized MCM-41 by modified aromatic carboxylic acids.
2009 Mar
Patents

Sample Use Guides

Diabetic geriatric patients received 900 mg Hydroxytoluic acid orally as a single dose or as a daily dose of up to 2.7g/day for 3 months. For patients receiving a single dose a 50 g glucose tolerance test was performed 2 hours after dosing, for longitudinal patients the glucose tolerance test was performed monthly or every two months. After a single 900 mg dose, plasma insulin levels showed considerable increases, plasma free fatty acid fell 2 hours after dosing with hydroxytoluic acid. Daily dosing of 1.8 g/day hydroxytoluic acid as the sole treatment allowed patients to control their diabetes but was not significantly different from controls. When added to the existing drug regimen patients receiving hydroxy toluic acid showed a smoothing of control of blood sugar with decreased needs of insulin or sulphonylurea.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 12:31:43 GMT 2023
Edited
by admin
on Sat Dec 16 12:31:43 GMT 2023
Record UNII
2Y32FEU3GB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Sodium 3-methylsalicylate
Systematic Name English
Benzoic acid, 2-hydroxy-3-methyl-, sodium salt (1:1)
Systematic Name English
Benzoic acid, 2-hydroxy-3-methyl-, sodium salt
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
251-202-2
Created by admin on Sat Dec 16 12:31:43 GMT 2023 , Edited by admin on Sat Dec 16 12:31:43 GMT 2023
PRIMARY
FDA UNII
2Y32FEU3GB
Created by admin on Sat Dec 16 12:31:43 GMT 2023 , Edited by admin on Sat Dec 16 12:31:43 GMT 2023
PRIMARY
CAS
32768-20-0
Created by admin on Sat Dec 16 12:31:43 GMT 2023 , Edited by admin on Sat Dec 16 12:31:43 GMT 2023
PRIMARY
EPA CompTox
DTXSID20186431
Created by admin on Sat Dec 16 12:31:43 GMT 2023 , Edited by admin on Sat Dec 16 12:31:43 GMT 2023
PRIMARY
PUBCHEM
23668291
Created by admin on Sat Dec 16 12:31:43 GMT 2023 , Edited by admin on Sat Dec 16 12:31:43 GMT 2023
PRIMARY